Veriskin
PrivateLast Round
Seed
Nov 10, 2022
Total Funding Raised
$8.03M
Company Overview
Veriskin is a medical device company that develops TruScore, a non-invasive, handheld diagnostic device that uses AI and hemodynamic measurements to assist clinicians in the rapid detection of skin cancer.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Veriskin Comparables
Compare Veriskin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| DermaSensor, Inc. | 88% | |
| Verisante Technology, Inc. | 78% | |
| MetaOptima Technology | 69% |
Veriskin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 10, 2022 | ||||
| Grant | Jul 14, 2022 | ||||
| Grant | Sep 22, 2021 | ||||
| Grant | Mar 1, 2020 | ||||
| Grant | May 1, 2016 |
Veriskin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| Arizona Tech Investors | Seed |
| NIH RADx | Grant |
| Frontier Angels | Seed |
| Ariel Savannah Angel Partners | Seed |
| TiE SoCal Angels | Seed |
| DigiLife | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 10, 2022
$1M round led by Pasadena Angels.
- Jul 14, 2022
$3M grant received from National Cancer Institute and NIH RADx.
Veriskin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Veriskin's valuation, stock price, and market status.
Is Veriskin a public or private company?
Veriskin is a private company.
What is the current stock price of Veriskin?
Veriskin is a private company with no public stock price. No recent secondary market data is available.
How much is Veriskin worth (valuation)?
Valuation information for Veriskin is not publicly available.
Can I buy Veriskin stock?
Veriskin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Veriskin's last funding round?
Veriskin's most recent funding round was Seed on November 10, 2022.
Who are the main investors in Veriskin?
Key investors in Veriskin include National Cancer Institute, Arizona Tech Investors, NIH RADx, Frontier Angels, Ariel Savannah Angel Partners.
Will Veriskin IPO soon?
No public IPO plans have been announced for Veriskin.
How can I track Veriskin secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Veriskin's secondary market activity and sign up for updates.